Course Introduction
HIV viral suppression and treatment cascade performance evaluation is an essential component of effective HIV programme management, public health accountability, and evidence-based resource allocation. It enables programme managers, health authorities, monitoring and evaluation specialists, implementing partners, and development agencies to determine whether people living with HIV are being diagnosed, linked to treatment, retained in care, and supported to achieve sustained viral suppression. A systematic evaluation approach helps identify service delivery gaps, understand differences in programme performance, and translate routine monitoring information into practical improvements in health outcomes.
The HIV treatment cascade provides a structured framework for assessing progress from knowledge of HIV status through treatment initiation, continued engagement in care, viral-load testing, and viral suppression. Evaluation must distinguish between the proportion of all people living with HIV who achieve suppression and the proportion of people receiving ART whose viral loads are suppressed, because these indicators answer different programme performance questions. Understanding the numerator, denominator, reporting period, and eligibility criteria for every indicator is fundamental to producing accurate results and avoiding misleading comparisons across facilities, districts, regions, and countries.
Viral-load monitoring provides essential evidence about treatment effectiveness and the extent to which programmes are achieving their clinical and public health objectives. However, a recorded viral-load result does not automatically establish complete programme performance: evaluators must also examine whether eligible clients received testing, whether results were returned and acted upon, whether elevated viral loads triggered appropriate follow-up, and whether repeat testing documented subsequent outcomes. The course therefore integrates clinical monitoring concepts with programme evaluation methods, emphasizing the interpretation of results within approved national guidelines and the distinction between individual clinical management and aggregate programme performance assessment.
High-quality evaluation depends on the completeness, consistency, timeliness, and reliability of information collected through electronic medical records, laboratory information systems, pharmacy records, patient monitoring tools, community follow-up systems, and routine health information platforms. Participants will learn how to reconcile data sources, assess missing or duplicated records, investigate discrepancies between ART registers and laboratory databases, and interpret viral-load coverage and suppression indicators cautiously. The programme also addresses cohort analysis, longitudinal monitoring, indicator validation, data-quality audits, and the responsible use of dashboards to identify performance changes and direct improvement efforts.
Equity is a central consideration in evaluating HIV treatment outcomes. Aggregate performance can conceal persistent differences in access, retention, and viral suppression among children, adolescents, young adults, men, pregnant and breastfeeding women, older adults, people with disabilities, key populations, and communities affected by distance, stigma, discrimination, insecurity, or financial barriers. Participants will explore methods for disaggregating results, assessing disparities without stigmatizing communities, and engaging affected populations in interpreting findings. The course emphasizes confidentiality, informed participation, data minimization, ethical reporting, and the protection of people living with HIV throughout the evaluation process.
The training combines evaluation theory, indicator development, quantitative analysis, practical case studies, performance dashboard interpretation, and the preparation of actionable recommendations. Participants will develop skills to formulate evaluation questions, construct a treatment cascade, assess viral-load testing coverage and suppression, investigate treatment interruptions, evaluate quality-improvement initiatives, and communicate findings to technical teams, senior decision-makers, funders, and community stakeholders. By the end of the programme, participants will be equipped to develop a structured evaluation plan that connects reliable evidence to measurable corrective actions, stronger service delivery, more equitable treatment outcomes, and sustainable HIV programme performance.
Duration
10 days
Who Should Attend
-
HIV programme managers responsible for treatment outcomes, service quality, and achievement of national or organizational HIV targets.
-
Monitoring and evaluation officers working with HIV treatment programmes, public health interventions, and donor-funded initiatives.
-
Strategic information specialists responsible for HIV indicators, routine reporting, data interpretation, and performance dashboards.
-
Public health professionals evaluating access to testing, ART initiation, treatment continuity, and viral suppression.
-
Ministry of Health officials and national or subnational HIV programme coordinators responsible for performance oversight.
-
Facility managers, ART clinic coordinators, and clinical team leaders seeking to improve treatment cascade performance.
-
Laboratory managers and viral-load focal persons involved in specimen tracking, result reporting, and laboratory data quality.
-
Epidemiologists, biostatisticians, and data analysts conducting HIV cohort analysis and programme performance assessments.
-
Implementing partner staff responsible for monitoring service delivery, validating results, and reporting programme achievements.
-
Development partner, donor, and grant management personnel overseeing HIV programme accountability and results frameworks.
-
Community-led organization representatives involved in treatment literacy, client engagement, retention, and differentiated service delivery.
-
Quality improvement teams responsible for investigating performance gaps and monitoring corrective actions.
-
Health information system officers managing electronic medical records, laboratory information systems, and reporting platforms.
-
Researchers and evaluators conducting operational research, implementation evaluations, or HIV service delivery assessments.
-
Policy analysts and health planners translating evaluation findings into strategic decisions and resource allocation priorities.
Course Objectives
-
Explain the structure and purpose of the HIV treatment cascade, including how diagnosis, ART coverage, retention, viral-load testing, and viral suppression indicators relate to programme effectiveness.
-
Develop a coherent evaluation framework linking programme objectives, evaluation questions, indicators, data sources, analytical methods, and practical decision-making requirements.
-
Calculate and interpret HIV cascade indicators using appropriate numerators, denominators, eligibility criteria, reporting periods, and documented assumptions.
-
Assess viral-load testing coverage, result availability, and viral suppression while distinguishing missing laboratory results from confirmed unsuppressed outcomes.
-
Apply appropriate quantitative methods to routine HIV programme data, including cohort analysis, trend analysis, stratification, confidence intervals where suitable, and comparison of performance across service delivery settings.
-
Evaluate data quality through completeness checks, consistency testing, record reconciliation, duplicate detection, verification procedures, and investigation of discrepancies between information systems.
-
Identify where and why clients disengage from treatment services by examining linkage, treatment initiation, missed appointments, interruptions, re-engagement, and retention patterns.
-
Assess disparities in cascade outcomes across relevant population groups and geographic areas while applying ethical, non-stigmatizing, and context-sensitive interpretation.
-
Examine the effectiveness of interventions such as differentiated service delivery, multi-month dispensing, community ART distribution, adherence support, and structured follow-up.
-
Develop performance dashboards and analytical reports that clearly communicate cascade gaps, viral-load outcomes, uncertainty, data limitations, and priority actions to decision-makers.
-
Formulate feasible quality-improvement recommendations with defined responsibilities, implementation timelines, resource requirements, and measurable follow-up indicators.
-
Produce an integrated HIV viral suppression and treatment cascade evaluation plan that supports accountability, continuous learning, ethical data use, and sustainable programme improvement.
Comprehensive Course Outline
Module 1: Foundations of HIV Treatment Cascade Performance Evaluation
-
Explain the public health rationale for evaluating HIV diagnosis, treatment access, continuity of care, and viral suppression as interconnected programme outcomes.
-
Map the client journey from HIV testing and diagnosis through linkage, ART initiation, continued treatment, viral-load monitoring, and suppression.
-
Differentiate programme inputs, activities, outputs, outcomes, and longer-term impacts within a results-based HIV evaluation framework.
-
Examine the roles of national HIV strategies, health facilities, implementing partners, laboratories, community organizations, and funding agencies in performance accountability.
Module 2: Global Targets, National Standards, and Evaluation Frameworks
-
Interpret the UNAIDS 95–95–95 framework and explain how its targets relate to broader population-level diagnosis, treatment, and viral suppression outcomes.
-
Review relevant WHO recommendations, national HIV treatment guidelines, indicator reference sheets, and approved reporting requirements.
-
Translate strategic targets into measurable evaluation questions, performance benchmarks, and facility or district improvement objectives.
-
Assess how changes in policy, programme financing, service delivery models, and reporting definitions affect interpretation of trends over time.
Module 3: Evaluation Design, Questions, and Methodological Choices
-
Formulate evaluation questions covering relevance, effectiveness, equity, implementation quality, efficiency, sustainability, and programme outcomes.
-
Develop a logic model connecting HIV programme resources and activities with treatment initiation, retention, viral-load monitoring, and suppression outcomes.
-
Select appropriate evaluation designs, including routine data analysis, retrospective cohort assessment, cross-sectional reviews, mixed-methods studies, and before-and-after assessments.
-
Define the evaluation population, observation period, inclusion criteria, comparison groups, limitations, ethical safeguards, and intended users of the findings.
Module 4: HIV Cascade Indicators and Operational Definitions
-
Define indicators for diagnosis coverage, ART coverage, treatment initiation, retention, viral-load testing coverage, result availability, and viral suppression.
-
Calculate each indicator using validated numerators and denominators, documenting the reporting period, eligibility rules, and data source.
-
Distinguish among suppression among clients with a reported result, suppression among eligible clients, and suppression among all people living with HIV.
-
Establish an indicator reference matrix that documents disaggregation requirements, reporting frequency, validation rules, and interpretation limitations.
Module 5: Viral-Load Monitoring and Suppression Assessment
-
Explain the programme significance of viral-load testing and its role in assessing response to ART and sustained treatment effectiveness.
-
Assess testing coverage, specimen collection, laboratory processing, result return, clinical review, and repeat-testing processes.
-
Interpret viral-load thresholds according to the applicable national guideline and assay definitions rather than assuming that all programmes use identical cut-offs.
-
Evaluate follow-up processes for elevated viral loads, including documented adherence support, repeat testing, clinical review, and appropriate management according to current protocols.
Module 6: HIV Data Sources and Information System Integration
-
Map data flows across testing services, ART registers, electronic medical records, pharmacy systems, laboratory information systems, and community follow-up tools.
-
Assess the strengths, weaknesses, reporting delays, and coverage limitations of routine programme data and supplemental evaluation datasets.
-
Develop reconciliation procedures for linking laboratory results with treatment records while accounting for duplicate identifiers, transfers, and incomplete demographic fields.
-
Examine interoperability, unique client identifiers, data exchange standards, system access controls, and continuity arrangements during information technology disruptions.
Module 7: Data Quality Assurance and Verification
-
Conduct structured data-quality assessments covering completeness, internal consistency, timeliness, validity, uniqueness, and agreement between source documents and reports.
-
Apply verification techniques such as source-document review, independent recalculation, record tracing, sample-based audits, and discrepancy resolution.
-
Investigate missing viral-load results, inconsistent ART status, implausible dates, duplicate records, and mismatches between laboratory and clinic databases.
-
Prepare data-quality findings that quantify the scale of identified problems, assess their effect on indicators, assign corrective responsibilities, and document resolution.
Module 8: Quantitative Analysis and Treatment Cohort Evaluation
-
Prepare and clean datasets for cascade analysis, including consistent date formats, eligibility criteria, treatment status definitions, and duplicate handling.
-
Calculate cascade proportions, testing coverage, suppression rates, retention measures, and changes in performance across reporting periods.
-
Conduct cohort analyses to assess treatment initiation, continuity, viral-load monitoring, suppression, interruption, and re-engagement over time.
-
Interpret missing observations, transfers, incomplete follow-up, changing denominators, and other sources of bias that may distort programme comparisons.
Module 9: Treatment Retention, Interruption, and Re-Engagement
-
Assess retention using clearly specified cohort definitions, observation windows, transfer rules, and treatment status classifications.
-
Identify patterns associated with missed appointments, treatment interruptions, delayed refills, mobility, and barriers to returning to care.
-
Evaluate tracing and re-engagement systems while distinguishing confirmed disengagement from undocumented transfers and incomplete records.
-
Recommend person-centred interventions that strengthen continuity, reduce unnecessary clinic burden, and support safe return to treatment services.
Module 10: Equity, Disaggregation, and Population-Specific Outcomes
-
Disaggregate cascade indicators by age, sex, geography, service delivery model, and other locally relevant characteristics where data quality and privacy permit.
-
Evaluate outcomes for children, adolescents, men, pregnant and breastfeeding women, older adults, people with disabilities, and underserved communities.
-
Examine how stigma, discrimination, transport costs, service accessibility, legal barriers, and confidentiality concerns may affect treatment engagement.
-
Apply small-cell suppression, appropriate aggregation, and other disclosure controls when reporting results for small or potentially identifiable populations.
Module 11: Qualitative Evaluation and Interpretation of Performance Gaps
-
Design interviews, focus group discussions, client journey reviews, and key informant consultations to investigate barriers behind quantitative results.
-
Explore perspectives from clients, caregivers, healthcare workers, laboratory teams, community organizations, and programme managers.
-
Triangulate qualitative findings with routine indicators to distinguish possible service delivery problems from data recording or reporting failures.
-
Document participant perspectives ethically and translate recurring themes into actionable explanations and improvement priorities without overstating causal conclusions.
Module 12: Evaluating Service Delivery Models and Quality Improvement
-
Assess differentiated service delivery approaches, multi-month dispensing, community ART distribution, appointment flexibility, and other locally implemented service models.
-
Compare eligible clients’ retention, treatment continuity, viral-load testing, and suppression outcomes across delivery models while considering selection differences.
-
Apply continuous quality-improvement methods to define performance problems, test corrective changes, monitor implementation, and assess subsequent results.
-
Develop improvement cycles with measurable aims, baseline values, responsible teams, review intervals, and documented decisions based on emerging evidence.
Module 13: Performance Dashboards, Data Visualization, and Reporting
-
Design clear cascade tables, trend charts, geographic comparisons, and performance summaries that accurately represent programme results.
-
Develop dashboard specifications covering indicator definitions, refresh schedules, data ownership, access permissions, quality flags, and drill-down requirements.
-
Communicate uncertainty, missing data, denominator changes, and comparability limitations to avoid misleading conclusions from headline percentages.
-
Prepare concise evaluation reports and executive briefs that connect findings with implications, priority recommendations, responsible stakeholders, and follow-up measures.
Module 14: Implementation Science, Digital Innovation, and Emerging Issues
-
Assess the appropriate use of electronic records, automated data-quality checks, decision-support tools, and digital reporting platforms in cascade evaluation.
-
Examine how automated alerts and analytical models can support follow-up while evaluating false alerts, incomplete data, bias, and operational feasibility.
-
Evaluate the effects of laboratory disruptions, medicine stock-outs, workforce constraints, funding changes, and service interruptions on treatment outcomes.
-
Consider emerging service delivery and monitoring innovations within current national guidance, ensuring that new technologies strengthen rather than replace clinical judgement and ethical oversight.
Module 15: Evaluation Ethics, Confidentiality, and Responsible Data Use
-
Apply informed consent requirements, confidentiality safeguards, ethical review procedures, and appropriate data minimization to evaluation activities.
-
Establish secure data handling, role-based access, de-identification, retention rules, and controlled sharing arrangements for sensitive HIV information.
-
Assess risks associated with linkage of clinical, laboratory, community, and demographic datasets, especially when working with small or marginalized populations.
-
Develop transparent reporting practices that protect participants, avoid stigmatizing interpretations, and ensure findings are communicated responsibly to authorized audiences.
Module 16: Evaluation Planning, Recommendations, and Action Implementation
-
Develop a comprehensive evaluation matrix specifying questions, indicators, data sources, methods, responsibilities, timelines, and expected deliverables.
-
Prioritize recommendations according to public health importance, equity implications, feasibility, resource requirements, and potential programme benefit.
-
Construct an action plan linking each identified performance gap to a responsible team, implementation deadline, measurable milestone, and verification method.
-
Present an integrated evaluation report and management briefing that establish how findings will inform service improvements, resource allocation, monitoring, and subsequent evaluation cycles.
Training Approach
This course will be delivered by our skilled trainers who have vast knowledge and experience as expert professionals in the fields. The course is taught in English and through a mix of theory, practical activities, group discussion and case studies. Course manuals and additional training materials will be provided to the participants upon completion of the training.
Tailor-Made Course
This course can also be tailor-made to meet organization requirement. For further inquiries, please contact us on: Email: training@upskilldevelopment.com Tel: +254 721 331 808
Training Venue
The training will be held at our Upskill Training Centre. We also offer training for a group (at a discount of 10% to 50%) at requested location all over the world. The Onsite course fee covers the course tuition, training materials, two break refreshments, buffet lunch, airport transfers, Upskill gift package, and guided tour.
Visa application, travel expenses, dinners, accommodation, insurance, and other personal expenses are catered by the participant
Certification
Participants will be issued with Upskill certificate upon completion of this course.
Airport Pickup and Accommodation
Airport pickup and accommodation is arranged upon request. For booking contact our Training Coordinator through Email: training@upskilldevelopment.com, +254 721 331 808
Terms of Payment:
Unless otherwise agreed between the two parties’ payment of the course fee should be done 3 working days before commencement of the training so as to enable us to prepare better.








